scholarly journals Surgical Management of Liver Metastases from Colorectal Carcinoma

2017 ◽  
Vol 01 (03) ◽  
pp. 163-170
Author(s):  
Lou-Anne Acevedo-Moreno ◽  
Federico Aucejo

AbstractColorectal carcinoma continues to be a leading cause in cancer-related mortality with more than 130,000 new cases diagnosed annually in the United States. About 50% of patients will develop colorectal cancer liver metastasis (CRLM). Liver resection continues to be the mainstay therapy in the management of CRLM and is associated with 25 to 60% 5-year survival. Alternative nonsurgical therapies offer modest survival when CRLM is unresectable. Herein, we provide an overview of key aspects of surgical approaches to the treatment of CRLM.

2016 ◽  
Vol 27 ◽  
pp. ii42
Author(s):  
K. Yanaga ◽  
K. Yoshida ◽  
T. Hasegawa ◽  
M. Ogawa

Author(s):  
Sayaf Alshareef ◽  
Nasser Alsobaie ◽  
Salman Aldeheshi ◽  
Sultan Alturki ◽  
Juan Zevallos ◽  
...  

Colorectal cancer (CRC) is the third most common cause of mortality in the United States (US). Differences in CRC mortality according to race have been extensively studied; however, much more understanding with regard to tumor characteristics’ effect on mortality is needed. The objective was to investigate the association between race and mortality among CRC patients in the US during 2007–2014. A retrospective cohort study using data from the Surveillance, Epidemiology, and End Results (SEER) Program, which collects cancer statistics through selected population-based cancer registries during in the US, was conducted. The outcome variable was CRC-related mortality in adult patients (≥18 years old) during 2007–2014. The independent variable was race of white, black, Asian/Pacific Islander (API), and American Indian/Alaska Native (others). The covariates were, age, sex, marital status, health insurance, tumor stage at diagnosis, and tumor size and grade. Bivariate analysis was performed to identify possible confounders (chi-square tests). Unadjusted and adjusted logistic regression models were used to study the association between race and CRC-specific mortality. The final number of participants consisted of 70,392 patients. Blacks had a 32% higher risk of death compared to whites (adjusted odds ratio (OR) 1.32; 95% confidence interval (CI) 1.22–1.43). Corresponding OR for others were 1.41 (95% CI 1.10–1.84). API had nonsignificant adjusted odds of mortality compared to whites (0.95; 95% CI 0.87–1.03). In conclusion, we observed a significant increased risk of mortality in black and American Indian/Alaska Native patients with CRC compared to white patients.


2016 ◽  
Vol 129 (24) ◽  
pp. 2983-2990 ◽  
Author(s):  
Yue Han ◽  
Dong Yan ◽  
Fei Xu ◽  
Xiao Li ◽  
Jian-Qiang Cai

HPB ◽  
2010 ◽  
Vol 12 (1) ◽  
pp. 37-42 ◽  
Author(s):  
Prosanto Chaudhury ◽  
Mazen Hassanain ◽  
Nathaniel Bouganim ◽  
Ayat Salman ◽  
Petr Kavan ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document